Rights and permissions
About this article
Cite this article
High-dose IL-2 best for metastatic renal cancer. Inpharma Wkly. 1409, 17 (2003). https://doi.org/10.2165/00128413-200314090-00040
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200314090-00040